Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (151-160 of 263) with videos related to

Pageof 27
Sort By:
American Journal of Human Genetics|May 1, 1991
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphismA Gaedigk, M Blum, R Gaedigk, et al.
Clinical Pharmacology and Therapeutics|September 1, 1979
Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapyM Eichelbaum, K W Köthe, F Hoffman, et al.
Journal of Chromatography. B, Biomedical Applications|October 20, 1995
Direct gas chromatographic determination of dechloroethylcyclophosphamide following microsomal incubation of cyclophosphamideF Bohnenstengel, S Johnson, U Hofmann, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatmentM Eichelbaum, K W Köthe, F Hoffmann, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tabletsM Eichelbaum, H J Dengler, A Somogyi, et al.
FEBS Letters|April 4, 2000
Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administrationK Eckhardt, I Nevo, R Levy, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1974
The physiological disposition of p-octopamine in manJ H Hengstmann, W Konen, C Konen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 29, 1998
Ocular pharmacokinetics of verapamil in rabbitsA Ettl, U Hofmann, A Daxer, et al.
Klinische Wochenschrift|November 15, 1985
Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidationC Zekorn, G Achtert, H J Hausleiter, et al.
Chemico-Biological Interactions|June 8, 1999
Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapineM Tugnait, E M Hawes, G McKay, et al.
Pageof 27

Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
American Journal of Human Genetics|May 1, 1991
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphismA Gaedigk, M Blum, R Gaedigk, et al.
Clinical Pharmacology and Therapeutics|September 1, 1979
Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapyM Eichelbaum, K W Köthe, F Hoffman, et al.
Journal of Chromatography. B, Biomedical Applications|October 20, 1995
Direct gas chromatographic determination of dechloroethylcyclophosphamide following microsomal incubation of cyclophosphamideF Bohnenstengel, S Johnson, U Hofmann, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatmentM Eichelbaum, K W Köthe, F Hoffmann, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tabletsM Eichelbaum, H J Dengler, A Somogyi, et al.
FEBS Letters|April 4, 2000
Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administrationK Eckhardt, I Nevo, R Levy, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1974
The physiological disposition of p-octopamine in manJ H Hengstmann, W Konen, C Konen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 29, 1998
Ocular pharmacokinetics of verapamil in rabbitsA Ettl, U Hofmann, A Daxer, et al.
Klinische Wochenschrift|November 15, 1985
Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidationC Zekorn, G Achtert, H J Hausleiter, et al.
Chemico-Biological Interactions|June 8, 1999
Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapineM Tugnait, E M Hawes, G McKay, et al.
Pageof 27